If passed, HB1382 would amend the Colorado Revised Statutes to include specific provisions about PANS and PANDAS, thereby impacting health insurance policies across the state. It aims to reduce barriers that currently exist in accessing appropriate medical care for children diagnosed with these conditions. By doing so, it sets a precedent for how insurance companies must operate regarding specialized health conditions, potentially improving overall health outcomes for affected youth.
Summary
House Bill 1382 aims to require all individual and group health benefit plans in Colorado to provide coverage for the diagnosis, treatment, and prophylaxis of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS). This legislation is designed to ensure that affected children have access to necessary medical therapies, including antibiotics, medication, and various behavioral therapies. The bill mandates that coverage aligns with clinical practice guidelines established by a consortium of medical professionals specialized in these disorders.
Sentiment
The sentiment surrounding HB1382 appears to be largely supportive among healthcare advocates and families affected by PANS and PANDAS. Supporters argue that the bill is critical for ensuring timely and effective treatment for these often debilitating conditions. Conversely, there may be concerns regarding the financial implications for insurance providers and the potential for increased premiums, which could generate opposition from some legislators and stakeholders in the insurance industry.
Contention
Notable points of contention surrounding the bill include concerns about the appropriateness of enforcing such coverage mandates on insurance providers. Opponents may argue that this could lead to increased healthcare costs and pressure the insurance market. Additionally, there may be discussions about the sufficiency of the scientific evidence supporting the mandatory coverage of these relatively newly recognized conditions, which could affect how the legislation is perceived by various parties involved.
State plan for medical assistance services and health insurance; pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.
Extends coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome by removing the sunset date of December 31, 2025, and mandating such coverage.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 of 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
An Act to Require Health Insurance Coverage for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections and Pediatric Acute-onset Neuropsychiatric Syndrome
An Act Requiring Health Insurance Coverage For Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections And Pediatric Acute-onset Neuropsychiatric Syndrome.
In casualty insurance, providing for coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans.(See HF 574.)